INTT Intest Corp.

inTEST to Present at Investor Conferences

inTEST to Present at Investor Conferences

MT. LAUREL, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets, including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications, today announced that the Company is scheduled to participate in the following investor conferences: (i) 2021 Colliers Virtual Institutional Investor Conference, and (ii) Lake Street Capital Markets 2021 Best Ideas Growth (BIG5) Virtual Conference.

Richard N. “Nick” Grant, Jr., President & CEO, and Duncan Gilmour, Chief Financial Officer, will be participating on behalf of the Company. The presentation materials utilized during the conference will be available on the Investor Relations section of inTEST’s website at .

2021 Colliers Virtual Institutional Investor Conference/ September 9, 2021

inTEST management will be hosting one-on-one meetings with investors at the 2021 Colliers Virtual Institutional Investor Conference, to be held online on Thursday September 9, 2021.

For those interested in arranging a one-on-one meeting with inTEST management, please contact your Colliers representative.

Lake Street Capital Markets 2021 Best Ideas Growth (BIG5) Virtual Conference / September 15, 2021

inTEST management will be hosting one-on-one meetings with investors at the Lake Street Capital Markets 2021 Best Ideas Growth (BIG5) Virtual Conference, to be held online on Wednesday September 15, 2021.

For those interested in arranging a one-on-one meeting with inTEST management, please contact your Lake Street Capital Markets representative.

About inTEST Corporation

inTEST Corporation is a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, medical, industrial, semiconductor and telecommunications. Backed by decades of engineering expertise and a culture of operational excellence, we solve difficult thermal, mechanical and electronic challenges for customers worldwide while generating strong cash flow and profits. Our strategy uses these strengths to grow and increase stockholder value by maximizing our businesses and by identifying, acquiring and optimizing complementary businesses. For more information visit .

Contacts   
inTEST Corporation  Investors:
Duncan Gilmour  Deborah K. Pawlowski
Treasurer and Chief Financial Officer  Kei Advisors LLC
Tel: (856) 505-8999   
   Tel: (716) 843-3908



EN
02/09/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Intest Corp.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

inTEST EMS Products Signs General Bussan Co., Ltd. as Exclusive Distri...

MT. LAUREL, N.J.--(BUSINESS WIRE)-- inTEST Electronic Test, a division of (NYSE American: INTT), announced today that inTEST EMS Products, a leading provider of manipulators, interface solutions, and docking systems for production Automated Test Equipment (ATE) solutions to the semiconductor industry, executed a strategic agreement with General Bussan Co., Ltd., a leading distributor and manufacturers’ representative for the semiconductor industry in Japan. This press release features multimedia. View the full release here: Mark Bradford, inTEST, (center) and representatives from General Bus...

 PRESS RELEASE

inTEST Corporation to Present at the Southwest IDEAS Conference

MT. LAUREL, N.J.--(BUSINESS WIRE)-- (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor (“semi”), today announced that Nick Grant, President & CEO, and Duncan Gilmour, Chief Financial Officer, will present and host investor meetings at the Southwest IDEAS Conference at The Statler in Dallas on Wednesday, November 20, 2024. The Company presentation is scheduled to begin at 7:55 a.m. Central T...

 PRESS RELEASE

inTEST Schedules Third Quarter 2024 Financial Results Conference Call ...

MT. LAUREL, N.J.--(BUSINESS WIRE)-- (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor (“semi”), announced it will release its third quarter 2024 financial results before the opening of financial markets on Friday, November 1, 2024. The Company will host a conference call and webcast that day to review its financial and operating results and discuss its corporate strategies and outlook. A qu...

 PRESS RELEASE

inTEST Corporation to Webcast Presentation at the iAccess Alpha Virtua...

MT. LAUREL, N.J.--(BUSINESS WIRE)-- (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor (“semi”), today announced that Nick Grant, President & CEO, and Duncan Gilmour, Chief Financial Officer, will present on September 24 and host investor meetings on September 25, 2024 at the iAccess Alpha Buyside Best Ideas Virtual Fall Conference. The inTEST presentation is scheduled for Tuesday, September...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch